Back to top
more

Globus Medical (GMED)

(Delayed Data from NYSE)

$86.25 USD

86.25
2,490,998

+1.60 (1.89%)

Updated Jun 26, 2026 04:00 PM ET

After-Market: $86.21 -0.04 (-0.05%) 7:58 PM ET

Zacks Rank:
Message not found:16923

2-Buy of 5   2      

Style Scores:
Message not found:17303

B Value D Growth C Momentum C VGM

Industry Rank:
Message not found:17304

Bottom 33% (163 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Fundamental Charts

Research for GMED

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

About Price to Book Value

The Price to Book ratio or P/B is calculated as market capitalization divided by its book value. (Book value is defined as total assets minus liabilities, preferred stocks, and intangible assets.) In short, this is how much a company is worth. Investors use this metric to determine how a company's stock price stacks up to its intrinsic value.

GMED 86.25 +1.60(1.89%)

Will GMED be a Portfolio Killer in June?

Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.

Click here - the GMED analysis is free »

Zacks News for GMED

Other News for GMED